These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 3359479
1. Dopamine inhibits calcium flux in the 7315a prolactin-secreting pituitary tumour. Login IS, Judd AM, Macleod RM. Cell Calcium; 1988 Feb; 9(1):27-31. PubMed ID: 3359479 [Abstract] [Full Text] [Related]
4. Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine. Judd AM, Login IS, Kovacs K, Ross PC, Spangelo BL, Jarvis WD, MacLeod RM. Endocrinology; 1988 Nov; 123(5):2341-50. PubMed ID: 2844508 [Abstract] [Full Text] [Related]
5. Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production. Koike K, Judd AM, Login IS, Yasumoto T, MacLeod RM. Neuroendocrinology; 1986 Nov; 43(3):283-90. PubMed ID: 2426623 [Abstract] [Full Text] [Related]
6. The effects of maitotoxin on 45Ca2+ flux and hormone release in GH3 rat pituitary cells. Login IS, Judd AM, Cronin MJ, Koike K, Schettini G, Yasumoto T, MacLeod RM. Endocrinology; 1985 Feb; 116(2):622-7. PubMed ID: 2578383 [Abstract] [Full Text] [Related]
7. Impaired calcium mobilisation in the 7315a prolactin-secreting pituitary tumour. Judd AM, Login IS, Jarvis WD, MacLeod RM. Cell Calcium; 1987 Jun; 8(3):189-96. PubMed ID: 3111713 [Abstract] [Full Text] [Related]
8. Role of calcium in dopaminergic regulation of TRH- and angiotensin II-stimulated prolactin release. Login IS, Judd AM, Kuan SI, MacLeod RM. Am J Physiol; 1991 Apr; 260(4 Pt 1):E553-60. PubMed ID: 1902061 [Abstract] [Full Text] [Related]
9. Dopamine receptor and adrenoceptor agonists inhibit prolactin release from MMQ cells. Judd AM, MacLeod RM. Eur J Pharmacol; 1991 Mar 19; 195(1):101-6. PubMed ID: 1676676 [Abstract] [Full Text] [Related]
10. Dopaminergic inhibition of anterior pituitary adenylate cyclase activity and prolactin release: the effects of perturbing calcium on catalytic adenylate cyclase activity. Schettini G, Hewlett EL, Cronin MJ, Koike K, Yasumoto T, MacLeod RM. Neuroendocrinology; 1986 Mar 19; 44(1):1-7. PubMed ID: 3024052 [Abstract] [Full Text] [Related]
11. Interactions of dopamine and neurotensin on calcium fluxes and prolactin release in normal rat pituitary cells. Login IS, Kuan SI, Judd AM, MacLeod RM. Endocrinology; 1990 Oct 19; 127(4):1948-55. PubMed ID: 1698150 [Abstract] [Full Text] [Related]
12. Pertussis toxin pretreatment abolishes dihydropyridine inhibition of calcium flux in the 235-1 pituitary cell line. Schettini G, Meucci O, Florio T, Grimaldi M, Landolfi E, Magri G, Yasumoto T. Biochem Biophys Res Commun; 1988 Feb 29; 151(1):361-9. PubMed ID: 2450538 [Abstract] [Full Text] [Related]
13. Dopaminergic reduction of intracellular calcium: the role of calcium influx. Login IS, Judd AM, MacLeod RM. Biochem Biophys Res Commun; 1988 Mar 15; 151(2):913-8. PubMed ID: 3348820 [Abstract] [Full Text] [Related]
14. Maitotoxin stimulates hormonal release and calcium flux in rat anterior pituitary cells in vitro. Schettini G, Koike K, Login IS, Judd AM, Cronin MJ, Yasumoto T, MacLeod RM. Am J Physiol; 1984 Oct 15; 247(4 Pt 1):E520-5. PubMed ID: 6496670 [Abstract] [Full Text] [Related]
15. Calcium mobilization potentiates prolactin release induced by protein kinase C activators. Koike K, Judd AM, Yasumoto T, MacLeod RM. Mol Cell Endocrinol; 1985 May 15; 40(2-3):137-43. PubMed ID: 3159606 [Abstract] [Full Text] [Related]
16. Calcium, cAMP, and dopamine affect single mammotrophs assayed by hemolytic plaques. Anderson JM, Keefer DA, Koritnik DD, Yasumoto T, Cronin MJ. Am J Physiol; 1985 Oct 15; 249(4 Pt 1):E337-44. PubMed ID: 2996362 [Abstract] [Full Text] [Related]
17. A possible role of arachidonate metabolism in the mechanism of prolactin release. Judd AM, Koike K, MacLeod RM. Am J Physiol; 1986 Mar 15; 250(3 Pt 1):E288-95. PubMed ID: 2420203 [Abstract] [Full Text] [Related]
18. Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone. Cronin MJ, Perkins SN, Keefer DA, MacLeod RM. Mol Cell Endocrinol; 1982 Oct 15; 28(2):229-46. PubMed ID: 7128925 [Abstract] [Full Text] [Related]
19. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells. Lamberts SW, van Koetsveld P, Verleun T. Cancer Res; 1987 Jul 15; 47(14):3667-71. PubMed ID: 3594432 [Abstract] [Full Text] [Related]